{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T08:58:53Z","timestamp":1785142733140,"version":"3.55.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>The objective of this study was to investigate the prevalence, clinicopathologic characteristics, management, and outcomes of patients with brain metastasis (BM) from gynecologic malignancies in a large hospital-based database.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>The National Cancer Database (NCDB) was accessed and patients with ovarian, uterine, or cervical cancer and BM were identified. We identified those who received radiation therapy (RT) as whole-brain radiation therapy (WBRT) or stereotactic radiosurgery (SRS). Kaplan-Meier curves were generated to determine median overall survival (OS) and compared with the log-rank test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 853 patients with BM were identified. The rate of BMs upon diagnosis was 0.4% (211\/57,160) for patients with cervical cancer, 0.2% (498\/243,785) for patients with uterine, and 0.2% (144\/92,301) for ovarian malignancies. Only 30.4% had isolated BM, while 52.2% had lung metastasis. Approximately half of the patients (50.1%) received chemotherapy, while brain RT was administered to 324 (38%) patients. Among patients who received brain RT, only 60 (18.5%) had SRS, while 264 (81.5%) had WBRT. Patients who underwent SRS had a better survival (n=47, median OS=9\u2009mo) than those who received WBRT (n=201, median OS=4.73\u2009mo, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.018), or those who did not receive any brain RT (n=370, median OS=4.01\u2009mo, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.007).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The incidence of BM among patients with gynecologic malignancies is rare and associated with poor survival. For select patients, SRS may be associated with prolonged survival.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000000689","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T17:48:49Z","timestamp":1585763329000},"page":"418-421","source":"Crossref","is-referenced-by-count":14,"title":["Brain Metastases From Gynecologic Malignancies"],"prefix":"10.1097","volume":"43","author":[{"given":"Dimitrios","family":"Nasioudis","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitra","family":"Persaud","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil K.","family":"Taunk","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Pennsylvania Health System"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawar A.","family":"Latif","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"R1-20230903","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2016.04.030","article-title":"Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain","volume":"142","author":"Divine","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R2-20230903","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/IGC.0000000000000554","article-title":"Factors predictive of improved survival in patients with brain metastases from gynecologic cancer: a single institution retrospective study of 47 cases and review of the literature","volume":"25","author":"Gressel","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3346\/jkms.2015.30.1.66","article-title":"A clinical analysis of brain metastasis in gynecologic cancer: a retrospective multi-institute analysis","volume":"30","author":"Kim","year":"2015","journal-title":"J Korean Med Sci"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.wneu.2016.01.062","article-title":"Gamma knife surgery for metastatic brain tumors from gynecologic cancer","volume":"89","author":"Matsunaga","year":"2016","journal-title":"World Neurosurg"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijgo.2011.02.014","article-title":"Changes in the management and outcome of central nervous system involvement from ovarian cancer since 1994","volume":"114","author":"Cormio","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11060-019-03094-2","article-title":"Efficacy of gamma knife radiosurgery in brain metastases of primary gynecological tumors","volume":"142","author":"Sadik","year":"2019","journal-title":"J Neurooncol"},{"key":"R7-20230903","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3892\/ol.2017.5621","article-title":"Stereotactic radiosurgery for brain metastasis from gynecological malignancies","volume":"13","author":"Kasper","year":"2017","journal-title":"Oncol Lett"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1748-717X-9-155","article-title":"Stereotactic radiosurgery (SRS) for brain metastases: a systematic review","volume":"9","author":"Nieder","year":"2014","journal-title":"Radiat Oncol"},{"key":"R9-20230903","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14791\/btrt.2017.5.2.87","article-title":"Outcomes in 20 gynecologic cancer patient with brain metastasis: a single institution retrospective study","volume":"5","author":"Kim","year":"2017","journal-title":"Brain Tumor Res Treat"},{"key":"R10-20230903","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/gyno.2001.6384","article-title":"The effect of radiation therapy on brain metastases from endometrial carcinoma: a retrospective study","volume":"83","author":"Mahmoud-Ahmed","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-014-1447-9","article-title":"Brain metastasis from ovarian cancer: a systematic review","volume":"119","author":"Pakneshan","year":"2014","journal-title":"J Neurooncol"},{"key":"R12-20230903","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00701-012-1576-x","article-title":"Radiosurgery to palliate symptoms in brain metastases from uterine cervix cancer","volume":"155","author":"Chung","year":"2013","journal-title":"Acta Neurochir (Wien)"},{"key":"R13-20230903","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1200\/JCO.2017.75.9589","article-title":"Whole-brain radiotherapy for brain metastases: evolution or revolution?","volume":"36","author":"Brown","year":"2018","journal-title":"J Clin Oncol"},{"key":"R14-20230903","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.280.17.1485","article-title":"Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial","volume":"280","author":"Patchell","year":"1998","journal-title":"JAMA"},{"key":"R15-20230903","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"JAMA"},{"key":"R16-20230903","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","article-title":"Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial","volume":"363","author":"Andrews","year":"2004","journal-title":"Lancet"},{"key":"R17-20230903","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1200\/EDBK_241345","article-title":"Modern management of central nervous system metastases in the era of targeted therapy and immune oncology","volume":"39","author":"Brastianos","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"R18-20230903","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/jog.13851","article-title":"Durable response by olaparib for a Japanese patient with primary peritoneal cancer with multiple brain metastases: a case report","volume":"45","author":"Sakamoto","year":"2019","journal-title":"J Obstet Gynaecol Res"},{"key":"R19-20230903","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.gore.2016.10.004","article-title":"Olaparib treatment for BRCA-mutant ovarian cancer with leptomeningeal disease","volume":"18","author":"Bangham","year":"2016","journal-title":"Gynecol Oncol Rep"},{"key":"R20-20230903","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/jco.2012.30.15_suppl.2013","article-title":"Phase I safety and pharmacokinetic (PK) study of veliparib in combination with whole brain radiation therapy (WBRT) in patients (pts) with brain metastases","volume":"30","author":"Mehta","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T04:03:24Z","timestamp":1693713804000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000689"}},"subtitle":["Prevalence and Management"],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000689","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,31]]}}}